In a recently updated edition of the dosimetry market, FMI has assessed the market valuation to be USD 3,144.10 million in 2024. The market continues to profit from rapidly increasing conditions like cardiovascular (CVD) diseases, cancer, and neurology-related diseases, which are raising the demand for dosimeters.
The market is bidding for a valuation of USD 4,882.60 million by 2034, expanding at an average 4.5% growth rate. Players seeking a greater share in this growing market are enhancing their product offerings and elevating their service delivery.
| Attributes | Key Insights |
|---|---|
| Dosimetry Market Size (2024E) | USD 3,144.10 million |
| Market Valuation (2034F) | USD 4,882.60 million |
| Value-based CAGR (2024 to 2034) | 4.5% |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
| Leading Product Type | Personal Electronic Dosimeters |
|---|---|
| Value Share (2024) | 60.80% |
The personal electronic dosimeters are frequently used dosimeters. These dosimeters account for about 60.80% of the global market share. The increasing importance of real-time display of accumulated dosage and dose-related information is raising the use of these dosimeters among healthcare staff. Another factor that is adding to the popularity of dosimeters is their easy-to-handle build.
Mirion Technologies is an established player and a popular provider of personal electronic dosimeters for hospital personnel, nuclear workers, and first responders. Continuous advancements in personal electronic dosimeters are projected to push sales in years to follow.
| Leading Modality | Wearable |
|---|---|
| Value Share (2024) | 66.80% |
By modality, the wearable segment occupies a massive 66.80% share in 2024. Wearables make up a large portion of the dosimetry market due to their common use as field-readable devices that are worn on the body for accumulated dose measurement.
Since wearables can be worn at any time of working, they are observing a heightened rate of acceptance among end users.
| Countries | Forecast CAGR (2024 to 2034) |
|---|---|
| The United States | 2.70% |
| Germany | 4.90% |
| Italy | 6.0% |
| Russia | 7.90% |
| China | 2.80% |
Sales of dosimeters in the United States are predicted to steadily expand at a 2.70% CAGR over the forecast period. The increasing cancer and geriatric population are contributing to this market’s growth. Further, investment in the latest technology to improve health protection is projected to sustain key players in this market throughout the years ahead.
Players are further investing in effective customer service departments to help customers select the appropriate radiation monitoring device to cost-effectively and safely meet their state and federal requirements. Some of the frequent users of dosimeters are diagnostic labs, dental labs, educational laboratories, hospitals, diagnostic labs, industrial testing facilities, and veterinary offices.
Use of active dosimetry systems is increasing among medical staff and physicians as it offers immediate insights regarding radiation exposure, helping them to take prompt action to effectively utilize radiation reduction measures.
The demand for dosimeters in Germany is anticipated to increase at an average of 4.90% CAGR over the next 10 years. The widespread prevalence of cancer, especially skin cancer, is a chief factor that is fueling the dosimetry market in the country. Cases of melanoma cancer are projected to accelerate rapidly in Germany, translating to profitable prospects for providers of dosimeters in the country.
Other key aspects that are supporting the market growth are surging radiation-based treatment and growing awareness about dosimeters. Key players in the country are emphasizing transparency in transactions, affordable price range, and superior quality personnel monitoring service to build consumer loyalty and encourage repeat business.
The sales of dosimeters in Russia are projected to witness a compelling 7.90% CAGR over the assessment period. The business of dosimeters appears to be as promising as the predictions.
Key players in the country are offering a wide portfolio of dosimetry technology in the industry, ranging from electrometers and dosemeters to smart solutions for quality assurance of sophisticated clinical radiation equipment.
Players in Russia are also offering a complete line of software and hardware products that target aspects like radiation protection and health physics to meet the present nuclear industry challenges.
The dosimetry industry in Italy is experiencing a growth rate of 6% over the forecast period. Key players in Italy offer a diversified range of comprehensive solutions designed for use in radiographic imaging rooms.
The primary reason behind the significant use of dosimeters among interventional staff is that their radiation exposure is higher than in other medical professions owing to scattered radiation. This makes the use of real-time dosimetry a top choice to easily observe, minimize, and manage radiation exposure so that they concentrate on protecting lives.
Growth of the dosimetry industry in China is projected to be at a consistent 2.80% CAGR. The country has observed significant installments of dosimeters in the historical period. Looking ahead, the installment rate is predicted to increase, especially in healthcare facilities, to monitor and manage the radiation exposed to hospital staff.
Since cancer cases are climbing, and simultaneously the diagnosis rates, the demand for new radiation therapy is also rising. Key players are thus investing in new radiation therapy to offer effective treatment solutions.
Additionally, the growing demand to modernize equipment and enhance clinical efficiency is going to be the driving force behind innovative new dosimetry solutions.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The dosimetry market is fragmented in nature, with limited players providing dosimeter solutions. Players are forming strategic alliances and focusing on system automation to gain more customers.
Key industry participants are developing affordable and reliable dosimeters that cater to various fields. Additionally, they are investing their funds in research and development to develop innovations that will help reduce the cancer burden on medical facilities.
A go-to strategy of competitive players is distribution agreements. Leading players are coming into distribution agreements to ensure stable earnings from end users. Players are also planning to expand into other geographical markets to raise their revenue sources and visibility.
Market contenders are making their pricing completely transparent to ensure their customers that there are no setup charges, no hidden fees, no mailing fees, and no processing fees. Consistently developing high-quality dosimeters, in addition to transparent transactions, are predicted to hold customers loyal to the company for a long time.
The dosimetry market indicate a valuation of USD 3,144.10 million in 2024.
Looking ahead to 2034, the current forecast projects a CAGR of 4.5% for the dosimetry industry.
FMI predicts lucrative opportunities worth USD 4,882.60 million by the year 2034.
Personal electronic dosimeters hold a significant market share in the forecast period.
Russia is predicted to be an investment hotspot for investors and stakeholders.
Fuji Electric Corporation of America, Polimaster Inc., and JP Laboratories Inc. are powerful players in the dosimetry industry.
| Market Estimated Size in 2023 | USD 6,805.43 million |
|---|---|
| Projected Market Value in 2033 | USD 12,895.19 million |
| Value-based CAGR from 2023 to 2033 | 6.6% |
| Expected Market Value (2023) | USD 7.88 billion |
|---|---|
| Anticipated Forecast Value (2033) | USD 16 billion |
| Projected CAGR (2023 to 2033) | 7.3% |
Explore Diagnostic Devices Insights
View Reports
Dosimetry Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
